rs12478601 — THADA THADA PCOS/Insulin Resistance

Intronic variant in THADA (thyroid adenoma associated) on chromosome 2p21; the C allele is a PCOS risk allele at the THADA locus (companion tag SNP to rs13429458, the original Han Chinese GWAS lead), tagging a haplotype that reduces THADA-mediated SERCA uncoupling, impairing ER calcium homeostasis in pancreatic beta cells and predisposing to PCOS and insulin secretion defects

See your personal result for THADA

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

THADA — The Energy Regulator Linking PCOS to Insulin Resistance

At chromosome 2p21, a gene called THADA11 THADA
thyroid adenoma associated; encodes an armadillo repeat-containing protein that acts as a SERCA uncoupling factor harbours one of the most robustly replicated genetic loci for polycystic ovary syndrome (PCOS). The rs12478601 C allele was first identified as a PCOS risk variant in 2011 and has since been confirmed across multiple ethnic groups, connecting the syndrome's hormonal features directly to a fundamental mechanism of cellular energy homeostasis.

The Mechanism

THADA functions as a SERCA uncoupling protein22 SERCA uncoupling protein
SERCA = sarco/endoplasmic reticulum Ca²⁺-ATPase, a pump that moves calcium from the cytoplasm into the ER lumen. When THADA is present and functional, it binds SERCA and reduces the efficiency of calcium pumping — effectively "wasting" some of the energy as heat rather than storing calcium. When THADA activity is reduced (as variants at this locus may cause), SERCA runs unchecked, over-filling ER calcium stores. In pancreatic beta cells, excess ER calcium disrupts the finely tuned calcium signalling required for insulin secretion33 excess ER calcium disrupts the finely tuned calcium signalling required for insulin secretion
THADA knockdown raises ER Ca²⁺ stores and reduces beta-cell responsiveness to GLP-1 and arginine stimulation, suggesting lower effective beta-cell mass. Impaired insulin secretion in the face of normal or elevated glucose — a hallmark of early insulin resistance — creates the metabolic backdrop on which PCOS develops.

The Evidence

The THADA locus at 2p21 was identified as a genome-wide significant PCOS susceptibility region by Chen et al. 201144 Chen et al. 2011
Genome-wide association study identifies susceptibility loci for PCOS on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011 in a Han Chinese cohort of >4,000 PCOS cases and 6,600 controls, with the lead SNP rs13429458 reaching OR 0.67, p=1.73×10⁻²³. rs12478601 is a companion tag SNP in the same THADA LD block, subsequently studied in multiple replication cohorts. The THADA association has been replicated in European-ancestry cohorts by Goodarzi et al. 201255 Goodarzi et al. 2012
Replication of DENND1A and THADA variants with PCOS in European cohorts. J Med Genet. 2012 and confirmed as part of the 14 susceptibility loci reported by the large-scale European meta-analysis by Day et al. 201866 Day et al. 2018
Large-scale GWAS meta-analysis of PCOS suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 2018 (10,074 PCOS cases, 103,164 controls).

The THADA-SERCA connection was established by Moraru et al. 201777 Moraru et al. 2017
THADA regulates the organismal balance between energy storage and heat production. Dev Cell. 2017. THADA loss in Drosophila produced obesity, reduced thermogenesis, and elevated ER calcium stores — phenotypes rescued by simultaneously reducing SERCA activity. Human cell experiments confirmed the SERCA uncoupling function. At the clinical level, Tian et al. 202088 Tian et al. 2020
PCOS-GWAS susceptibility variants in THADA, INSR, TOX3, and DENND1A are associated with metabolic syndrome or insulin resistance in women with PCOS. Front Endocrinol. 2020 showed that in 2,082 Han Chinese PCOS women, the CC genotype at rs12478601 was associated with a measurably different metabolic syndrome rate, while Cui et al. 201399 Cui et al. 2013
Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women. Hum Reprod. 2013 found CC homozygotes had elevated LDL cholesterol, linking the risk genotype to downstream cardiovascular metabolic consequences.

Practical Actions

Women carrying one or two copies of the C allele face a meaningfully elevated PCOS risk through the insulin secretion pathway. The primary actionable implication is monitoring for features of insulin resistance (hyperinsulinaemia, elevated fasting insulin, impaired glucose tolerance) before full PCOS develops, since the THADA mechanism acts specifically through beta-cell dysfunction rather than primary androgen excess. Dietary strategies that reduce the beta-cell glucose load — particularly limiting refined carbohydrates that trigger large insulin pulses — address the specific mechanism this variant affects. Inositol supplementation (myo-inositol or D-chiro-inositol) has a growing evidence base as an insulin sensitiser specifically in PCOS, distinct from general metabolic interventions.

Interactions

rs12478601 in THADA operates in parallel with two other replicated PCOS loci in the database: rs2479106 and rs7852296 (both in DENND1A), which act through a different pathway — elevated androgen biosynthesis in theca cells. THADA variants tag the metabolic/insulin-secretion arm of PCOS pathogenesis, while DENND1A variants tag the androgenic arm. Women carrying risk alleles at both loci may face the most severe PCOS phenotype, combining impaired insulin secretion with elevated androgen production. This interaction is worth noting for clinicians interpreting combined genomic results.

Genotype Interpretations

What each possible genotype means for this variant.

TT Normal Risk Normal

Common genotype — typical PCOS susceptibility

You carry the T/T genotype at rs12478601 in THADA. The T allele is the population-major allele globally (~61%) and is associated with typical PCOS susceptibility. This genotype does not confer elevated PCOS risk through the THADA pathway.

CT Elevated PCOS Risk Intermediate

One copy of the PCOS risk allele — moderately elevated susceptibility

The CT genotype places you on an elevated-risk haplotype for PCOS through the insulin secretion pathway at the THADA 2p21 locus (Chen et al. 2011). The metabolic consequences are dose-dependent: one C allele produces intermediate changes in beta-cell responsiveness to GLP-1 stimulation compared to the TT baseline. Elevated fasting insulin and impaired glucose tolerance are the earliest laboratory markers of this pathway's activation, and they can appear years before frank PCOS diagnosis.

CC High PCOS Risk High Risk

Two copies of the PCOS risk allele — substantially elevated susceptibility

For CC homozygotes, the THADA pathway contributes its maximum genetic loading to PCOS susceptibility. Cui et al. 2013 (Hum Reprod, n=1,731 PCOS cases) found the CC genotype was specifically associated with elevated LDL cholesterol (p=0.02), while Tian et al. 2020 (n=2,082 PCOS women) found metabolic syndrome rates differed significantly by THADA genotype. The SERCA uncoupling mechanism (Moraru et al. 2017) means that beta-cell calcium homeostasis is disturbed even before PCOS is clinically apparent — early insulin secretory impairment can appear as elevated postprandial insulin with normal fasting glucose (compensated insulin resistance). This is also the metabolic backdrop that makes PCOS-associated LDL elevation more likely: hyperinsulinaemia upregulates hepatic VLDL production.